Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Clinical trial NCT00352859 · TERMINATED

Trial details

NCT number: NCT00352859
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2006-08-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.